Preoperative Biochemical Predictors of Outcome in Patients With Hip Fracture
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01280253 |
Recruitment Status
:
Completed
First Posted
: January 20, 2011
Last Update Posted
: November 15, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Hip Fracture |
Study Type : | Observational |
Actual Enrollment : | 999 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Can Biochemical Tests Predict Outcome in Patients With Hip Fracture? |
Study Start Date : | January 2011 |
Actual Primary Completion Date : | August 2014 |
- Mortality [ Time Frame: 30 days ]
- Morbidity [ Time Frame: 30 day ]Infectious complications Cardiovascular complications Thromboembolic complications Respiratory complications Renal complications Surgical complications
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients presenting with out of hospital hip fracture at University Hospital Lund Sweden
- Informed consent
- Blood sampling within 3 hrs of first contact with healthcare
Exclusion Criteria:
- No consent can be obtained
- Non-operative management
- Followup through the Swedish National Quality for Hip fracture patients not possible
- High energy trauma

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01280253
Sweden | |
Skane University Hospital, Lund | |
Lund, Skane, Sweden, 22285 |
Principal Investigator: | Peter Bentzer, MD, PhD | Skane University Hospital |
Responsible Party: | Region Skane |
ClinicalTrials.gov Identifier: | NCT01280253 History of Changes |
Other Study ID Numbers: |
USILAN-2 2010 ( Other Grant/Funding Number: Anna och Edwin Berger Foundation ) 1837 ( Other Grant/Funding Number: Region Skane ALF ) |
First Posted: | January 20, 2011 Key Record Dates |
Last Update Posted: | November 15, 2016 |
Last Verified: | November 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | Upon reasonable request |
Keywords provided by Region Skane:
Predictor outcome biochemical |
Additional relevant MeSH terms:
Fractures, Bone Hip Fractures Wounds and Injuries |
Femoral Fractures Hip Injuries Leg Injuries |